Abstract
Although dramatic improvements in cancer survival statistics have occurred over the past 5 decades and are well documented in the literature, the same has not been true for detailing the unwanted incidental adverse effects following multimodal cancer treatment. The dramatic gains in 5-year survival has been compiled by cancer site in a SEER tabulation marking the passing of 50 % level for all cancers at the turn of this century. (American Cancer Society: Cancer Facts and Figures 1995). At issue and unresolved is the price for the success and how to best measure and grade these adverse toxicity effects which persist and progress over time detracting from the cancer survivor’s quality of life.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
American Cancer Society (1995) Cancer facts and figures. Atlanta, American Cancer Society
American Joint Committee on Cancer (AJCC) (2002) Cancer staging manual. 6th ed. Springer
Anacak Y, Yalman D, Ozsaran Z et al (2001) Late radiation effects to the rectum and bladder in gynecologic cancer patients: the comparison of LENT/SOMA and RTOG/EORTC late-effects scoring systems. Int J Radiat Oncol Biol Phys 50:1107–1112. http://ctep.info.nih.gov/CTC3/ctc.htm. Accessed 1 April 2003
Bragg DG, Rubin P, Hricak H (2002) Oncologic imaging, 2nd edn. WB Saunders Company, Philadelphia, PA
Cox JD, Stetz J, Pajak TF (1995) Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31:1341–1346
CTCAE v3.0 (2003) Development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 13(3):176–181
Davidson SE, Burns M, Routledge J et al (2002) Short report: a morbidity scoring system for clinical oncology practice: questionnaires produced from the LENT SOMA scoring system. Clin Oncol (R Coll Radiol) 14:68–69
Davidson SE, Burns MP, Routledge JA et al (2003a) The impact of radiotherapy for carcinoma of the cervix on sexual function assessed using the LENT SOMA scales. Radiother Oncol 68:241–247
Davidson SE, Burns MP, Routledge JA et al (2003b) Assessment of morbidity in carcinoma of the cervix: a comparison of the LENT SOMA scales and the Franco-Italian glossary. Radiother Oncol 69:195–200
Denis F, Garaud P, Bardet E et al (2003) Late toxicity results of the GORTEC 94–01 randomized trial comparing radiotherapy with concomitant radiochemotherapy for advanced-stage oropharynx carcinoma: comparison of LENT/SOMA, RTOG/EORTC, and NCI-CTC scoring systems. Int J Radiat Oncol Biol Phys 55:93–98
Fajardo LF, Berthrong M, Anderson RE (2001) Radiation pathology. Oxford University Press, USA
Federative Committee on Anatomical Terminology (FCAT) (1998) Terminologia Anatomica: International Anatomical Terminology. Stuttgart, Georg Thieme Verlag
Fedyk ER, Jones D, Critchley HO et al (2001) Expression of stromal-derived factor-1 is decreased by IL-1 and TNF and in dermal wound healing. J Immunol 166:5749–5754
Fehlauer F, Tribius S, Holler U et al (2003) Long-term radiation sequelae after breast-conserving therapy in women with early-stage breast cancer: an observational study using the LENT-SOMA scoring system. Int J Radiat Oncol Biol Phys 55:651–658
Forestiere AA, Goepfert H, Maor M et al (2003) Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349:2091–2098
Hoeller U, Tribius S, Kuhlmey A et al (2003) Increasing the rate of late toxicity by changing the score? A comparison of RTOG/EORTC and LENT/SOMA scores. Int J Radiat Oncol Biol Phys 55:1013–1018
Husband JES, Reznek RH (1998) Imaging in oncology. ISIS Medical Media, Oxford
LENT SOMA scales all for anatomic sites. (1995). Int J Radiat Oncol Biol Phys 30;31(5):1049–1091
Mercado AM, Padgett DA, Sheridan JF et al (2002) Altered kinetics of IL-1, Il-1, and KGF-1 gene expression in early wounds of restrained mice. Brain Behav Immun 16:150–162
Miller AB, Hoogstraten B, Staquet M et al (1981) Reporting results of cancer treatment. Cancer 47:207–214
Movsas B (2003) Quality of life in oncology trials: a clinical guide. Semin Radiat Oncol 13:189–202
Petak I, Houghton JA (2001) Shared pathways: death receptors and cytotoxic drugs in cancer therapy. Pathol Oncol Res 7:95–106
Routledge JA, Burns MP, Swindell R et al (2003) Evaluation of the LENT-SOMA scales for the prospective assessment of treatment morbidity in cervical carcinoma. Int J Radiat Oncol Biol Phys 56:502–510
Rubin P (2001) Clinical Oncology, 8th edn. WB Saunders, Philadelphia, PA
Rubin P, Casarett GW (1968) Clinical Radiation Pathology. Saunders, Philadelphia, PA
Rubin P, Constine S, Fajardo L et al (1995a) Overview of Late Effects of Normal Tissues (LENT) scoring system. Int J Radiat Oncol Biol Phys 31:1041–1042
Rubin P, Constine LS, Marks L, Okunieff P (eds) (2007) Late Effects of Cancer Treatment on Normal Tissues: Cured I, Lent. Springer, Berlin Heidelberg, New York
Rubin P, Johnston CJ, Williams JP et al (1995b) A perpetual cascade of cytokines postirradiation leads to pulmonary fibrosis. Int J Radiat Oncol Biol Phys 33:99–109
Tawfiq N, Lagarde P, Stockle E, et al (2000) Conservative treatment of extremity soft tissue sarcomas. Functional evaluation using LENT-SOMA scales and Enneking scoring. Cancer Radiother (French) 4:421–7
Trotti A (2002) The evolution and application of toxicity criteria. Sem Radiat Oncol 12:1–3
Trotti A, Bentzen MS (2004) The need for adverse effects reporting standards in oncologyclinical trials. J Clinc Oncol 22:19–22
Trotti A, Rubin P (2003) Introduction. Sem Radiat Oncol 13:175
Trotti A, Byhardt R, Stetz J et al (2000) Common toxicity criteria: Version 2.0. an improved reference for grading the acute effects of cancer treatment: impact on radiotherapy. Int J Radiat Oncol Biol Phys 47:13–47
Trotti A, Colevas DA, Setser A et al (2003) CTCAE v3.0: Development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 13:176–181
Trotti A, Pajak T, Gwede C, Paulus R, Cooper J, Forastiere A, Ridge J, Watkins-Bruner D, Garden A, Ang K, Curran W (2007) TAME: development of a new method for summarising adverse events of cancer treatment by the Radiation Therapy Oncology Group. Lancet Oncol 8(7):613–624. Pubmedid: 17543584
Werner-Wasik M, Pequignot E, Leeper D, Hauck W, Curran W Jr (2000) Predictors of severe esophagitis include use of concurrent chemotherapy, but not the length of irradiated esophagus: a multivariate analysis of patients with lung cancer treated with nonoperative therapy. Int J Radiat Oncol Biol Phys 48(3):689–696
World Health Organization Icd 10 (1992) International Statistical Classification of Diseases and Related Health Problems. 10th ed. American Psychiatric Publishing
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Trotti, A.M., Rubin, P. (2014). Biograding of Normal Tissue TNM Toxicity Taxonomy: Scoring the Adverse Effects of Cancer Treatment. In: Rubin, P., Constine, L., Marks, L. (eds) ALERT - Adverse Late Effects of Cancer Treatment. Medical Radiology(). Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-72314-1_7
Download citation
DOI: https://doi.org/10.1007/978-3-540-72314-1_7
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-72313-4
Online ISBN: 978-3-540-72314-1
eBook Packages: MedicineMedicine (R0)